Pharm-a-Care Laboratories Pty Ltd v Commonwealth of Australia (No 13)

The parties in this case were Pharm-a-Care Laboratories Pty Ltd and the Commonwealth of Australia. The dispute centred on the final approval of the payment of settlement distribution scheme administration costs. This matter was heard in the Federal Court of Australia. The central issue before the court was whether the costs claimed by the Commonwealth for the administration of the settlement distribution scheme were reasonable and necessary, and whether the court had the jurisdiction to approve the payment of those costs in a representative proceeding.

The court examined the criteria for assessing the reasonableness of costs in representative proceedings, including the nature and complexity of the case, the amount of money involved, and the necessity of the costs incurred. The court also considered the procedural fairness of the application process and the adequacy of the documentation provided by the Commonwealth. The Federal Court found that the costs claimed were reasonable and necessary, and that the process followed was fair and transparent. The court held that it had jurisdiction to approve the payment of these costs in a representative proceeding, and that the criteria for assessing the reasonableness of costs were met.

The court's decision was that the application for final approval of the payment of settlement distribution scheme administration costs should be granted. The court found that the Commonwealth had demonstrated that the costs were necessary and reasonable, and that the process for seeking approval was fair and transparent. The court also noted that the costs were a small fraction of the overall settlement amount and that the settlement had brought significant benefits to the class members. The court's final orders were that the application for final approval of the payment of settlement distribution scheme administration costs be granted, and that the Commonwealth be reimbursed for the costs claimed.